References
- Leonardi C. L., Powers J. L., Matheson R. T., Goffe B. S., Zitnik S., Wang A., et al. Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349: 2014–22
- Reich K., Nestle F. O., Papp K., Ortonne J. P., Evans R., Guzzo C., et al. EXPRESS study investigators. Infliximab induction and maintenance therapy for moderate‐to‐severe psoriasis: A phase III, multicentre, double‐blind trial. Lancet 2000; 366: 1367–74
- Patel T., Gordon K. B. Adalimumab: Efficacy and safety in psoriasis and rheumatoid arthritis. Dermatol Ther 2004; 17: 427–31
- Mease P. J., Goffe B. S., Metz J., VanderStoep A., Finck B., Burge D. J. Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial. Lancet 2000; 356: 385–90
- Flendrie M., Vissers W. H., Creemers M. C., de Jong E. M., van de Kerkhof P. C., van Riel P. L. Dermatological conditions during TNF‐blocking therapy in patients with rheumatoid arthritis: A prospective study. Arthritis Res Ther 2005; 7: R666–76
- Wright R. C. Atopic dermatitis‐like eruption precipitated by infliximab. J Am Acad Dermatol 2003; 49: 160–1
- Vergara G., Silvestre J. F., Betlloch I., Vela P., Albares M. P., Pascual J. C. Cutaneous drug eruption to infliximab: Report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002; 138: 1258–9
- Kent P. D., Davis J. M., Davis M. D., Matteson E. L. Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis. Arthritis Rheum 2002; 46: 2257–8
- Thielen A. M., Kuenzli S., Saurat J. H. Cutaneous adverse events of biological therapy for psoriasis: Review of the literature. Dermatology 2005; 211: 209–17
- Burge D. Etanercept and squamous cell carcinoma. J Am Acad Dermatol 2003; 49: 358–9
- Bovenschen H. J., Tjioe M., Vermaat H., de Hoop D., Witteman B. M., Janssens R. W., et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol 2006; 154: 880–4
- Smith K. J., Skelton H. G. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1‐Fc fusion complex therapy. J Am Acad Dermatol 2001; 45: 953–6
- Bleumink G. S., ter Borg E. J., Ramselaar C. G., Stricker B. H. C. Etanercept‐induced subacute cutaneous lupus erythematosus. Rheumatology 2001; 40: 1317–19
- Gillum P. S., Golitz L. E. Psoriasiform dermatitis. Textbook of dermatopathology, R. L Barnhill. McGraw‐Hill, USA 1998; 55–7
- Weedon D., editors. Major tissue reaction patterns. Skin pathology. 2002; 4, 2nd ed
- Weedon D., editors. The lichenoid reaction pattern. Skin pathology. 2002; 41, 2nd ed